12/9/2020 7:57:00 PM
Arcus Biosciences Expands Partnerships With WuXi Biologics To Develop Anti-CD39 Antibody For Treatment Of Cancer
10/29/2020 7:52:25 AM
Arcus To Collaborate With AstraZeneca On Registrational Trial For Domvanalimab Plus Imfinzi In Stage III NSCLC
7/7/2020 4:20:40 PM
Arcus Biosciences Appoints Bob Goeltz As CFO
5/28/2020 11:09:50 PM
Arcus Biosciences Prices Underwritten Public Offering Of 11 Mln Shares At $27.50/shr
5/27/2020 7:14:09 AM
Gilead Sciences, Arcus Biosciences Enter 10-year Partnership To Co-develop Cancer Immunotherapies
5/26/2020 4:14:33 PM
Arcus Biosciences Appoints David Lacey To Its Board Of Directors
3/11/2020 8:02:58 AM
Arcus Biosciences Announces New Employment Inducement Grants
2/26/2020 8:16:44 AM
Arcus Biosciences, Taiho Pharma Announce Taiho's Exercise Of Its Option For License To AB122 In Japan& Asian Countries
12/12/2019 9:06:30 AM
Arcus Biosciences Adds Patrick Machado To Board
3/5/2019 4:29:05 PM
Arcus Biosciences Q4 Loss/share $0.28 Vs. Loss $5.98 Year Ago
1/4/2019 8:32:23 AM
Arcus Biosciences CFO And COO Jennifer Jarrett To Step Down, Effective Jan. 11
10/22/2018 8:31:56 AM
Arcus Biosciences Appoints Kristen Hege To Its Board